Skip to main content

Day: March 12, 2022

HII Celebrates 170 Graduates of The Apprentice School at Newport News Shipbuilding Ceremony

2022 Apprentice School at Newport News Shipbuilding Commencement Chris Rose (Homer L. Ferguson Award Recipient) speaks during the 2022 Apprentice School at Newport News Shipbuilding Commencement Ceremony.NEWPORT NEWS, Va., March 12, 2022 (GLOBE NEWSWIRE) — Global engineering and defense technologies provider HII (NYSE:HII) hosted commencement exercises today for 170 graduates of the company’s Apprentice School at Newport News Shipbuilding (NNS). The ceremony was held at Liberty Live Church in Hampton. Newport News Shipbuilding President Jennifer Boykin began the event by addressing the graduates as the shipyard’s newest leaders. “I want you to know how proud I am of each of you for everything that you’ve accomplished,” Boykin said. “Today is just the next step towards your leadership role at Newport News Shipbuilding,...

Continue reading

VÍS: Framboð til stjórnar og tilnefningarnefndar VÍS vegna aðalfundar 2022

Aðalfundur Vátryggingafélags Íslands hf. verður haldinn fimmtudaginn 17. mars 2022 kl. 16:00 í höfuðstöðvum félagsins, Ármúla 3, 108 Reykjavík, auk þess sem gefinn er kostur á rafrænni þátttöku á fundinum. Framboðsfrestur vegna stjórnar og tilnefningarnefndar Vátryggingafélag Íslands hf. rann út þann 12. mars 2022 kl. 16:00. Meðfylgjandi eru upplýsingar um þá aðila sem gefið hafa kost á sér til setu í stjórn og varastjórn annars vegar, og í tilnefninganefnd hins vegar. Er það mat stjórnar að öll framboð séu gild sbr. 63. gr. a. hlutafélagalaga nr. 2/1995. Þar sem fimm einstaklingar hafa boðið sig fram til aðalstjórnar, tveir til varastjórnar og þrír einstaklingar hafa boðið sig fram til setu í tilnefningarnefnd er ljóst að sjálfkjörið er í stjórn og tilnefningarnefnd. Önnur fundargögn tengd hluthafafundi má nálgast á vef félagsins: https://vis.is/hluthafafundir/.                                                                                                         ...

Continue reading

Osisko Green Acquisition Limited Reports 2021 Financial Results

TORONTO, March 11, 2022 (GLOBE NEWSWIRE) — Osisko Green Acquisition Limited (TSX:GOGR) (the “Corporation”) is reporting its financial results as at December 31, 2021 and for the period from inception of the Corporation on July 8, 2021 to December 31, 2021. The Corporation is also announcing that there are no material updates regarding its search for target businesses with which it may complete its qualifying acquisition. The Corporation’s audited annual financial statements, along with the accompanying management’s discussion and analysis have been filed on the System for Electronic Document Analysis and Retrieval (“SEDAR”) and may be viewed by interested parties under the Corporation’s profile at www.sedar.com or the Corporation’s website at www.osiskogreen.com. About Osisko Green Acquisition Limited The Corporation is a special...

Continue reading

Liquid Media Announces Issuance of Cease Trade Order by the British Columbia Securities Commission to Investors Residing In British Columbia, Canada

VANCOUVER, British Columbia, March 11, 2022 (GLOBE NEWSWIRE) — Liquid Media Group Ltd. (the “Company”, “Liquid Media” or “Liquid”) (Nasdaq: YVR) discloses the issuance of a cease trade order (“CTO”) by the British Columbia Securities Commission (“BCSC”) under National Instrument 51-102 – Continuous Disclosure Obligations effective March 9, 2022, as a result of the Company not having filed its audited annual financial statements, accompanying management’s discussion and analysis and annual information form for the financial year ended November 30, 2021 (together, the “Annual Filings”). As previously announced on March 4, 2022, the Company has experienced unexpected delays in consolidating financial information from, and completing purchase accounting for its recently acquired operations. However, the Company is actively and expeditiously...

Continue reading

Global Care Capital Announces Closing of Initial Tranche Pursuant to Investor Agreement

NOT FOR RELEASE TO US WIRE SERVICES OR DISTRIBUTION IN THE UNITED STATES VANCOUVER, British Columbia, March 11, 2022 (GLOBE NEWSWIRE) — Global Care Capital Inc. (CSE: HLTH, FRANKFURT: L6V2) (the “Company” or “Global Care”) a global investment company which engages in early stage investment opportunities in private and public companies, is pleased to announce the initial closing under the convertible securities purchase agreement, the details of which are described in the Company’s release of February 25, 2022 and the issuance of an unsecured zero-coupon convertible securities with a principal amount of US$744,000 for a purchase price of US$600,000 and 6,339,872 shares in satisfaction of a fee payable to the investor at a deemed price of $0.05 per Share. All the securities issued under the initial closing are subject to a statutory...

Continue reading

Reservoir Capital Corp. Update on Nigerian Dispute

VANCOUVER, British Columbia, March 11, 2022 (GLOBE NEWSWIRE) — (CSE: REO) – Reservoir Capital Corp. (“REO” or the “Company“) would like to provide an update on the ongoing dispute with a Nigerian shareholder (see the news release filed on the Company’s SEDAR profile on May 7, 2021 for further details on the dispute and related litigation). As a result of this dispute, the Company has suffered partial payment of dividends from Nigerian hydro company Mainstream Energy Solutions Ltd (“MESL”) from late 2020 until the present. Of the Company’s $4,850,621 in combined dividend income in 2020 and 2021, $2,450,600 has been withheld and accrued as a result of the dispute. The Company has received assurance from representatives of the disputing Nigerian shareholder that (i) litigation filed in Nigerian...

Continue reading

Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer

BRACAnalysis CDx is now the only germline test approved by FDA as a companion diagnostic for treatment of HER2 negative high-risk early-stage breast cancer SALT LAKE CITY, March 11, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the U.S. Food and Drug Administration (FDA) has approved Myriad’s BRACAnalysis® CDx test for use as a companion diagnostic to identify patients with germline BRCA-mutated (gRBCAm) HER2 negative, high-risk early-stage breast cancer who may benefit from Lynparza®(olaparib). “This most recent regulatory approval confirms the benefits of using biomarkers to help guide care for patients with breast cancer,” said Nicole Lambert, chief operating officer, Myriad Genetics. “Data from the OlympiA trial and numerous other clinical...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.